Results 21 to 30 of about 142,557 (303)
Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C [PDF]
, 2001 Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators.
Haslinger, Bettina +4 more
core +1 more source
Frontiers in Medicine, 2022 IntroductionUF insufficiency is a major limitation in PD efficiency and sustainability. Our study object to investigate the efficacy of intraperitoneal inflammation marker, IL-6 level as a predictor of UF insufficiency in continuous ambulatory peritoneal
Qianhui Song +19 more
doaj +1 more source
Incidence and outcome of encapsulating peritoneal sclerosis [PDF]
, 2016 Background: Studies report variation in the incidence and outcomes of encapsulating peritoneal sclerosis (EPS). This study reports the incidence and outcome of EPS cases in a national cohort of peritoneal dialysis (PD) patients.
Mactier, Robert A. +2 more
core +2 more sources
Peritoneal dialysis during peritonitis [PDF]
Kidney International, 1981 Peritonitis during peritoneal dialysis is the most frequent complication associated with this dialysis technique. We studied patients undergoing peritoneal dialysis when they were without peritonitis and during episodes of clinical infection. Peritonitis was associated with a significantly decreased dialysate effluent volume, increased absorption of ...
John D. Bower +3 more
openaire +2 more sources
Renal Replacement Therapy, 2019 Background Diabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world.
Yukio Maruyama +9 more
doaj +1 more source
Ultrastructural changes of the peritoneum in a rabbit model of peritoneal dialysis [PDF]
, 2013 Background/Aim. The number of patients with end-stage renal diseases treated with chronic dialysis is increasing over the last years. Long-term peritoneal dialysis is associated with progressive development of structural and functional alterations of ...
Jovanović Nataša +7 more
core +1 more source
Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report
BMC Nephrology, 2018 Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos +5 more
doaj +1 more source
Peritoneal dialysis in older adults: evaluation of clinical, nutritional, metabolic outcomes, and quality of life [PDF]
, 2018 The number of older adults requiring dialysis is increasing worldwide, whereas the use of peritoneal dialysis (PD) in this population is lower respect to younger patients, despite the theoretical advantages of PD respect to hemodialysis.
Aceto, Paola +10 more
core +1 more source
Calciphylaxis: A successful outcome whilst on peritoneal dialysis
Bulletin de la Dialyse à Domicile, 2019 Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar +5 more
doaj +1 more source
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. [PDF]
, 2020 Intraperitoneal vancomycin is the first-line therapy in the management of peritoneal dialysis (PD)-related peritonitis. However, due to the paucity of data, vancomycin dosing for peritonitis in patients on automated peritoneal dialysis (APD) is empiric ...
Kraft, Walter K. +6 more
core +1 more source